Zobrazeno 1 - 10
of 41
pro vyhledávání: '"N. V. Muravyev"'
Autor:
N. E. Leonov, M. S. Klenov, A. M. Churakov, T. S. Konkova, E. A. Miroshnichenko, Yu. N. Matyushin, N. V. Muravyev, V. A. Tartakovsky
Publikováno v:
Russian Chemical Bulletin. 71:1634-1640
Publikováno v:
Антибиотики и Химиотерапия, Vol 69, Iss 5-6, Pp 72-84 (2024)
The problem of infectious endocarditis (IE) still retains its importance due to high mortality rates and the development of severe complications. Modern IE is a polyethological disease, the occurrence and development of which can be caused by pathoge
Externí odkaz:
https://doaj.org/article/2efc1760ddca4766be5f2f7f56a4e8c8
Publikováno v:
Parodontologiya. 26:335-342
Relevance. The etiology of alveolitis distinguishes infectious and traumatic factors, which determine the relevant drugs for preventing the inflammatory process after tooth extraction and local treatment of the developed alveolitis. Purpose – the s
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 3, Pp 293-299 (2024)
According to the World Health Organization (WHO), worldwide, annual influenza epidemics lead to approximately 3–5 million cases of severe forms of the disease and 250–500 thousand deaths. The problem of the course and outcomes of influenza is als
Externí odkaz:
https://doaj.org/article/ae9917b64a38426bb195b16e25e21b88
Publikováno v:
Антибиотики и Химиотерапия, Vol 69, Iss 3-4, Pp 95-101 (2024)
According to the currently available data from large cohort studies, patients with immuno-inflammatory rheumatic diseases (IIRDs) are at increased risk of infectious complications, including influenza, compared to the general population. Vaccinations
Externí odkaz:
https://doaj.org/article/f9554b5a7b7942a88a7384c4cb15b47d
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 2, Pp 192-202 (2024)
Currently, methotrexate (MT) remains one of the immunosuppressive drugs most commonly used in rheumatology. However, its effect on the immunogenicity of vaccines has until recently been studied only to a limited extent, which has led to the lack of c
Externí odkaz:
https://doaj.org/article/6f9c22d60bd74a92a54c79f4015d1a88
Autor:
B. S. Belov, N. V. Muravyeva
Publikováno v:
Антибиотики и Химиотерапия, Vol 69, Iss 1-2, Pp 65-73 (2024)
In modern conditions, patients with immuno-inflammatory rheumatic diseases (IIRD) are at significant risk of influenza, pneumococcal and herpes viral infections, as well as COVID-19, in some cases fatal. The most effective way to prevent infectious d
Externí odkaz:
https://doaj.org/article/b25b8a0b1de44c8780a59ebbaf6e5410
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 1, Pp 24-31 (2024)
The aim – to study risk factors for severe COVID-19 in patients with rheumatic diseases (RD).Patients and methods. The study included medical histories of 464 patients with RD who were admitted at the V.A. Nasonova Research Institute of Rheumatolog
Externí odkaz:
https://doaj.org/article/78f2a1529abe488f8b54e8b5e667fe09
Autor:
S. O. Salugina, A. V. Torgashina, E. Yu. Borzova, V. V. Rameev, V. R. Gorodetskiy, E. S. Fedorov, N. V. Muravyeva
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 6, Pp 711-722 (2024)
The aim – to present the experience of diagnosis, management, and therapy with IL-1 inhibitors in patients with Schnitzler’s syndrome (SchS) according to a multicenter Russian cohort.Materials and methods. In an observational retrospective study
Externí odkaz:
https://doaj.org/article/3ef03064569c46a69d9d20a51383e7e4
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 72-78 (2023)
Objective: to study the efficacy and safety of the Gam-COVID-Vac vaccine in patients with immunoinflammatory rheumatic diseases (IRD) in a prospective study.Material and methods. The study included 42 patients with IRD and 57 individuals without IRD
Externí odkaz:
https://doaj.org/article/af35124be5be47899fbe1a48f77be5d1